During the past decade, Clinical Research of Central Florida conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 19 clinical trials were completed, i.e. on average, 90.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research of Central Florida" #1 sponsor was "Pfizer" with 5 trials, followed by "Urovant Sciences GmbH" with 4 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "AEON Biopharma, Inc." with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research of Central Florida" #1 collaborator was "PPD" with 2 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research of Central Florida" are "Overactive Bladder" (6 trials), "Migraine" (4 trials), "Type 2 Diabetes Mellitus" (4 trials), "Cardiovascular Disease" (3 trials) and "Hot Flashes" (2 trials). Many other conditions were trialed in "Clinical Research of Central Florida" in a lesser frequency.

Most popular intervention types in "Clinical Research of Central Florida" are "Drug" (33 trials), "Other" (3 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "placebo" (4 trials), "Vibegron" (3 trials), "ABP-450" (2 trials) and "Eptinezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research of Central Florida" are 32 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research of Central Florida". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Clinical Research of Central Florida, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research of Central Florida, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".